Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Use of BCG polysaccharide and Nucleic acid preparation in preparation of medicine for oral cavity local medication

A technology of BCG polysaccharide nucleic acid and local administration, which is applied in the direction of drug combination, pharmaceutical formula, medical preparations containing active ingredients, etc., and can solve the problem of direct action on the lesion site, inability to satisfy local administration, and insufficient medication. Convenience and other issues, to achieve the effect of enhancing the total number of T cells, low toxicity, and convenient medication

Inactive Publication Date: 2003-08-06
CHENGDU INST OF BIOLOGICAL PROD
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the traditional method of applying BCG polysaccharide nucleic acid clinically is intramuscular injection. Although the curative effect of the injection route is affirmative, it has the following disadvantages: one is that the clinical injection route is inconvenient to use, and the other is that BCG Bacterial polysaccharide nucleic acid has a

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Use of BCG polysaccharide and Nucleic acid preparation in preparation of medicine for oral cavity local medication

Examples

Experimental program
Comparison scheme
Effect test
No Example Login to View More

PUM

PropertyMeasurementUnit
Average weightaaaaaaaaaa
Login to View More

Abstract

The present invention relates to a new application of bacille Calmette-Guerin (BCG) polysaccharide nucleic acid in preparation of medicine for oral cavity local medication to obtain double immunoregulation to cure the diseases of chronic bronchitis, common cold and asthma, etc. Said invention also provides the medicine composition made of bacille Calmette-Guerin polysaccharide nucleic acid with effective dose and adding pharmaceutically-acceptable auxiliary material through a certain preparation process. Said medicine composition can be taken in by means of oral cavity local medication mode, and has the double immunoregulation function, and can be used for curing the diseases of chronic bronchitis, common cold and asthma, etc.

Description

technical field [0001] The present invention relates to the use of BCG polysaccharide nucleic acid, specifically, the use of BCG polysaccharide nucleic acid in the preparation of medicines for local oral administration. Background technique [0002] Chronic bronchitis, asthma, allergic rhinitis, and allergic skin diseases are all common and frequently occurring diseases in spring. Clinically, there are many antibacterial, antihistamine, and hormonal drugs. It is not a difficult problem to control the symptoms of these diseases when they attack, but they cannot control their repeated attacks. The application and promotion of BCG polysaccharide nucleic acid has added an effective method to control the recurrence of these diseases. However, the traditional method of applying BCG polysaccharide nucleic acid clinically is intramuscular injection. Although the curative effect of the injection route is affirmative, it has the following disadvantages: one ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/715A61P11/00A61P37/02A61P37/08
Inventor 晏子厚屈戈周如娇何莉曹慧徐永革吴先勇杨永芳
Owner CHENGDU INST OF BIOLOGICAL PROD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com